The guideline of the Korean College of Helicobacter and Upper Gastrointestinal Research group for Helicobacter pylori infection was first produced in 1998. Definite indication for H. pylori eradication is early gastric cancer in addition to the previous indications of peptic ulcer (PUD) including scar lesion and marginal zone B cell lymphoma (MALT type). Though treatment regimen was similar, Japan government declared the inclusion of H. pylori eradication in patients with H. pylori-associated chronic gastritis, suggesting the treatment guideline is quite different between Korea and Japan from February 21, 2013. The prime rationale of Japanese extended treatment guideline for H. pylori infection was based on the drastic intention to prevent gastric cancer according to their beliefs that H. pylori eradication can decrease gastric cancer incidence as well as mortality. In this review, the discrepancy in treatment guideline between Korea and Japan will be explained. (J Cancer Prev 2013;18:107-112) 
INTRODUCTION
The principle of "innocent until proven guilty" isaccepted in the legal field of society, but in the field of infectious diseases, the principle of "guilty until proven innocent" applies, a part of Koch's definition of infection. In case of Helicobacter pylori infection, despite of International Agency for Research on Cancer (IARC)'s definition that H. pylori is class I, definite, carcinogen for gastric cancer, the principle "the eradication of H. pylori can decrease or prevent gastric cancer" remains obscure and under debates. 1 Though proactive preventive measures are adopted for cancers that are suspected to be caused by infection, for instances, hepatitis B and C virus, human papilloma virus, and some other parasite or protozoa for the prevention of hepatocellular carcinoma, cervical or esophageal cancer, bladder cancer, etc, and thereby resulting in a reduction of cancer related deaths, obscure debates still exist between H. pylori infection and the prevention of gastric cancer. Based on enormous medical costs that the cost of gastric cancer treatment in Japan has been reported currentlyaround 300 billion yen per year and will exceed 500 billion yen annually if measures are not taken for a decade or so, the Japanese government decided to eradicate H. pylori in patients with gastritis, indication not permitted in Korea yet, from February 21, 2013. [2] [3] [4] These facts cast the homework "should we follow up 
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. 4 The new strategy could be one that combined primary prevention by H. pylori eradication with secondary prevention using surveillance of high-risk patients.
In Japan, H. pylori infection was approved as an official (Fig. 1) .
KOREAN PERSPECTIVE ON THE PREVENTION OF GASTRIC CANCER RELEVANT TO H. PYLORI INFECTION
Early diagnostic strategies might be the best proven way of gastric cancer prevention, available program in either Korea and Japan as public health interventions in gastric cancer, but the mortality rates of 20-40/100,000 still rendered gastric cancer troublesome malignancy. H. pylori infection, smoking, and salt are strong independent risk factors for gastric cancer besides of individual genetic risk condition. Fresh fruits, vegetables and certain micronutrients such as selenium, vitamin C reduce the risk, but foods that can inhibit H. pylori viability, colonization and infection may reduce cancer risk, for which Korean red ginseng, licorice special extracts, S-allyl cysteine from garlic, some probiotics, and even Korean gimchi cuisine were proven to very effectively impose anti-bacterial activities, exert anti-mutagenic actions as well as rejuvenating activities. Though these findings should be proved to be "evidence based medicine", great deals might be the adoption of generalized policy to "eliminate bug to achieve gastric cancer prevention" or siTRP (short-term intervention to eliminate premalignancy (Fig. 2 
